Purdue Pharma Settlements Continue

September 9, 2019 3:30 am

STAMFORD, Conn. (AP) – OxyContin maker Purdue Pharma says it’s continuing to negotiate a settlement over the toll of opioids, a day after some state attorneys general sent a letter to their colleagues saying talks with the company had reached an impasse and that they expected the company to file imminently for bankruptcy protection. In the statement, the company said it believes “a settlement that benefits the American public now is a far better path than years of wasteful litigation and appeals.” The company is being sued by more than 2,000 state, local and tribal governments. The first federal trial on opioids is scheduled to begin next month, adding pressure on the parties to settle. Two attorneys general told officials in other states the company had rejected offers from the states.